We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The Sanofi-Alynylam alliance has been in place since 2014, with the latest development seeing the two companies each take their own commercialisation lead on patisiran and fitusiran, respectively.